(Q40624637)

22 September 2017

1 reference

title

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease (English)

1 reference

22 September 2017

M J Kendall

1

1 reference

PubMed ID

7913813

22 September 2017

I Rajman

series ordinal

2

1 reference

22 September 2017

1 March 1994

1 reference

22 September 2017

1 reference

22 September 2017

10

1 reference

22 September 2017

220-232

1 reference

22 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199410030-00004

22 September 2017

0 references

cites work

Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?

1 reference

12 December 2020

Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.

1 reference

12 December 2020

Critical comments on recent literature. SCRAAPHY about MAPHY from HAPPHY

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.

1 reference

12 December 2020

Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity

1 reference

12 December 2020

Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?

1 reference

12 December 2020

Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension

1 reference

12 December 2020

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

12 December 2020

Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol

1 reference

12 December 2020

The central and peripheral hemodynamics of celiprolol

1 reference

12 December 2020

Celiprolol Has No Direct or Indirect Relaxing Effects in Isolated Arteries and Veins

1 reference

12 December 2020

A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.

1 reference

12 December 2020

Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet.

1 reference

12 December 2020

Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone

1 reference

12 December 2020

A comparison of celiprolol and atenolol in the treatment of hypertension

1 reference

12 December 2020

The effects of beta-adrenergic blocking agents on atherosclerosis and its complications

1 reference

12 December 2020

The effect of beta-blockade on platelet function and fibrinolytic activity

1 reference

12 December 2020

Hypertension. Relationship with other risk factors

1 reference

12 December 2020

A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction.

1 reference

12 December 2020

A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

A review of the clinical experience with celiprolol in angina

1 reference

12 December 2020

Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity

1 reference

12 December 2020

Safety profile of celiprolol

1 reference

12 December 2020

Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles

1 reference

12 December 2020

Propranolol in angina pectoris: Duration of improved exercise tolerance and circulatory effects after acute oral administration

1 reference

12 December 2020

Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease

1 reference

12 December 2020

Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions

1 reference

12 December 2020

Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol

1 reference

12 December 2020

Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol

1 reference

12 December 2020

Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients

1 reference

12 December 2020

The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.

1 reference

12 December 2020

Beta adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: a report from the DHSS Hypertension Care Computing Project (DHCCP)

1 reference

12 December 2020

Results of the Austrian celiprolol postmarketing surveillance study

1 reference

12 December 2020

Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins

1 reference

12 December 2020

Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly

1 reference

12 December 2020

Celiprolol in angina pectoris: a controlled study

1 reference

12 December 2020

Beta-adrenergic stimulation enhances translocation, processing and synthesis of lipoprotein lipase in rat heart cells

1 reference

12 December 2020

Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients

1 reference

12 December 2020

Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.

1 reference

12 December 2020

The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers

1 reference

12 December 2020

The functional importance of beta 1 and beta 2 adrenoceptors in the human heart

1 reference

12 December 2020

Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol

1 reference

12 December 2020

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

1 reference

12 December 2020

Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris

1 reference

12 December 2020

Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris

1 reference

12 December 2020

Comparison of the antihypertensive effects of celiprolol and acebutolol

1 reference

12 December 2020

Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease

1 reference

12 December 2020

A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension

1 reference

12 December 2020

Celiprolol in the treatment of hypertension: a comparison with propranolol

1 reference

12 December 2020

Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs hydralazine in hypertensive hyperlipidemic rabbits.

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

Celiprolol and verapamil in the treatment of essential hypertension

1 reference

12 December 2020

Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy

1 reference

12 December 2020

Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II

1 reference

12 December 2020

Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects

1 reference

12 December 2020

Pharmacology of celiprolol

1 reference

12 December 2020

Angina, ischemia, and effort tolerance with vasodilating β-blockers

1 reference

12 December 2020

Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension

1 reference

12 December 2020

Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina

1 reference

12 December 2020

The role of beta receptor blockade in preventing sudden death

1 reference

12 December 2020

Adrenergic mechanisms in control of plasma lipid concentrations

1 reference

12 December 2020

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

1 reference

12 December 2020

The medical treatment of angina pectoris

1 reference

12 December 2020

Effect of short-term beta blockade on serum lipid levels and on the interaction of LDL with human arterial proteoglycans

1 reference

12 December 2020

Reduction of enzyme levels by propranolol after acute myocardial infarction

1 reference

12 December 2020

Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations

1 reference

12 December 2020

Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats

1 reference

12 December 2020

Celiprolol: an investigation of a new beta 1-, alpha 2-adrenoceptor antagonist in asthmatic patients

1 reference

12 December 2020

British MRC trial of treatment for mild hypertension--a more favorable interpretation

1 reference

12 December 2020

Celiprolol: pharmacokinetics and duration of pharmacodynamic activity

1 reference

12 December 2020

Long-term humoral and hemodynamic effects of celiprolol.

1 reference

12 December 2020

Clinical safety and efficacy of celiprolol

1 reference

12 December 2020

Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.

1 reference

12 December 2020

Reversal of cardiac and vascular hypertrophy by antihypertensive therapy

1 reference

12 December 2020

Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension

1 reference

12 December 2020

Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial

1 reference

12 December 2020

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

1 reference

12 December 2020

Systemic and renal hemodynamic effects of celiprolol in essential hypertensives

1 reference

12 December 2020

The role of sympathetic activity in atherogenesis: effects of beta-blockade

1 reference

12 December 2020

Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.

1 reference

12 December 2020

The effect of celiprolol on peripheral circulation in healthy volunteers

1 reference

12 December 2020

Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure

1 reference

12 December 2020

Doxazosin increases low density lipoprotein receptor activity.

1 reference

12 December 2020

Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients

1 reference

12 December 2020

Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension

1 reference

12 December 2020

10.2165/00002018-199410030-00004

Identifiers

DOI

1 reference

PubMed ID

7913813

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

7913813